Role of the MSCT in Evaluation of the Congenital Cardiovascular Anomalies
Role of the Multi-Slice Computed Tomography in Evaluation of the Congenital Cardiovascular Anomalies
1 other identifier
observational
50
0 countries
N/A
Brief Summary
Congenital heart diseases (CHDs) are considered as the most common congenital birth defects, comprising 1% of all live births . Echocardiography remains a first-line non-invasive imaging tool for establishing the diagnosis and follow-up in most patients .This method is operator dependent and limited by an acoustic window . Traditional angiography is typically utilized as the gold standard modality for diagnosing CHD, but it is an invasive method and need general anseathsia with dose of radiation exposure .After recent developments in CT and MR technologies, cardiac catheterization is no longer necessary for diagnosis .
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jun 2021
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 4, 2021
CompletedFirst Posted
Study publicly available on registry
March 8, 2021
CompletedStudy Start
First participant enrolled
June 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2022
CompletedMarch 8, 2021
March 1, 2021
1 year
March 4, 2021
March 4, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
accuracy of the MSCT in congenital cardiovascular anomalies
comparison between sensitivity and accuracy of MSCT in detection of congenital cardiovascular anomalies with detection rate by cardiac catheterization or surgery
baseline
Interventions
use of MSCT as a diagnostic tool in evaluation of patients with congenital cardiovascular anomalies
Eligibility Criteria
All patients attending to the cardiovascular departement and diagnosed as congenital cardiovascular anomalies
You may qualify if:
- patients suffering from congenital cardiovascular diseases diagnosed either clinically or by echocardiographic examination.
You may not qualify if:
- orthopenic patient patients with hypersensitivity to contrast , medium and poor renal function .
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (1)
Goitein O, Salem Y, Jacobson J, Goitein D, Mishali D, Hamdan A, Kuperstein R, Di Segni E, Konen E. The role of cardiac computed tomography in infants with congenital heart disease. Isr Med Assoc J. 2014 Mar;16(3):147-52.
PMID: 24761701RESULT
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- specialist
Study Record Dates
First Submitted
March 4, 2021
First Posted
March 8, 2021
Study Start
June 1, 2021
Primary Completion
June 1, 2022
Study Completion
September 1, 2022
Last Updated
March 8, 2021
Record last verified: 2021-03